Kuros Biosciences AG (SWX:KURN)

Kuros Biosciences AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,054	806	128	54	63	66
Market Cap Growth	368.09%	528.00%	138.81%	-14.90%	-4.70%	20.42%
Enterprise Value	1,037	793	114	34	38	54
Last Close Price	27.46	21.35	3.49	1.47	1.93	2.02
PS Ratio	10.20	10.66	3.82	2.99	4.57	16.40
PB Ratio	13.75	13.71	2.26	0.78	0.82	0.78
P/TBV Ratio	30.24	33.12	8.15	2.67	3.01	2.45
P/FCF Ratio	-	393.96	-	-	-	-
P/OCF Ratio	1284.96	256.57	-	-	-	-
EV/Sales Ratio	10.03	10.50	3.41	1.90	2.77	13.27
EV/EBITDA Ratio	159.85	385.86	-	-	-	-
EV/EBIT Ratio	269.01	7414.24	-	-	-	-
EV/FCF Ratio	-1538.60	387.93	-	-	-	-
Debt / Equity Ratio	0.02	0.03	0.04	0.03	0.03	0.03
Debt / EBITDA Ratio	0.28	0.66	-	-	-	-
Debt / FCF Ratio	-	0.88	-	-	-	-
Asset Turnover	1.10	0.97	0.44	0.21	0.15	0.04
Inventory Turnover	1.14	1.18	1.27	1.47	2.33	1.96
Quick Ratio	1.68	1.64	2.22	2.20	2.72	7.69
Current Ratio	2.25	2.14	2.77	2.49	2.91	8.76
Return on Equity (ROE)	-8.62%	-6.44%	-16.18%	-20.02%	-9.33%	-14.18%
Return on Assets (ROA)	2.57%	0.09%	-4.12%	-7.06%	-5.90%	-8.09%
Return on Capital (ROIC)	3.43%	0.11%	-4.90%	-8.21%	-6.59%	-8.81%
Return on Capital Employed (ROCE)	4.60%	0.20%	-	-	-	-
Earnings Yield	-0.58%	-0.53%	-10.70%	-27.17%	-11.95%	-17.39%
FCF Yield	-0.06%	0.25%	-7.14%	-14.41%	-9.13%	-14.04%
Buyback Yield / Dilution	-38.66%	-1.69%	-7.91%	-3.37%	-34.86%	-53.69%

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.